Showing 1 - 7 results of 7 for search 'Litton, E', query time: 0.02s
Refine Results
-
1
-
2
Safety and efficacy of iron therapy on reducing red blood cell transfusion requirements and treating anaemia in critically ill adults: A systematic review with meta-analysis and tr... by Shah, A, Fisher, S, Wong, H, Roy, N, McKechnie, S, Doree, C, Litton, E, Stanworth, S
Published 2018Journal article -
3
Normalising comparative effectiveness trials as clinical practice by Briffa, T, Symons, T, Zeps, N, Straiton, N, Tarnow-Mordi, WO, Simes, J, Harris, IA, Cruz, M, Webb, SA, Litton, E, Nichol, A, Williams, CM
Published 2021Journal article -
4
Risk of infection associated with intravenous iron preparations: protocol for updating a systematic review by Shah, A, Sugavanam, A, Reid, J, Palmer, A, Dickson, E, Brunskill, S, Doree, C, Oliver, C, Acheson, A, Baikady, R, Bampoe, S, Litton, E, Stanworth, S
Published 2019Journal article -
5
Risk of infection associated with administration of intravenous iron: A systematic review and meta-analysis by Shah, AA, Donovan, K, Seeley, C, Dickson, EA, Palmer, AJR, Doree, C, Brunskill, S, Reid, J, Acheson, AG, Sugavanam, A, Litton, E, Stanworth, SJ
Published 2021Journal article -
6
Effect of antiplatelet therapy on survival and organ support-free days in critically ill patients with COVID-19: a randomized clinical trial by Bradbury, CA, Lawler, PR, Stanworth, SJ, McVerry, BJ, McQuilten, Z, Higgins, AM, Mouncey, PR, Al-Beidh, F, Rowan, KM, Berry, LR, Lorenzi, E, Zarychanski, R, Arabi, YM, Annane, D, Beane, A, van Bentum-Puijk, W, Bhimani, Z, Bihari, S, Bonten, MJM, Brunkhorst, FM, Buzgau, A, Buxton, M, Carrier, M, Cheng, AC, Cove, M, Detry, MA, Estcourt, LJ, Fitzgerald, M, Girard, TD, Goligher, EC, Goossens, H, Haniffa, R, Hills, T, Huang, DT, Horvat, CM, Hunt, BJ, Ichihara, N, Lamontagne, F, Leavis, HL, Linstrum, KM, Litton, E, Marshall, JC, McAuley, DF, McGlothlin, A, McGuinness, SP, Middeldorp, S, Montgomery, SK, Morpeth, SC, Murthy, S
Published 2022Journal article -
7
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial by Arabi, YM, Gordon, AC, Derde, LPG, Nichol, AD, Murthy, S, Beidh, FA, Annane, D, Swaidan, LA, Beane, A, Beasley, R, Berry, LR, Bhimani, Z, Bonten, MJM, Bradbury, CA, Brunkhorst, FM, Buxton, M, Buzgau, A, Cheng, A, De Jong, M, Detry, MA, Duffy, EJ, Estcourt, LJ, Fitzgerald, M, Fowler, R, Girard, TD, Goligher, EC, Goossens, H, Haniffa, R, Higgins, AM, Hills, TE, Horvat, CM, Huang, DT, King, AJ, Lamontagne, F, Lawler, PR, Lewis, R, Linstrum, K, Litton, E, Lorenzi, E, Malakouti, S, McAuley, DF, McGlothlin, A, Mcguinness, S, McVerry, BJ, Montgomery, SK, Morpeth, SC, Mouncey, PR, Orr, K, Parke, R, Parker, JC
Published 2021Journal article